Business Context and Reporting Period
This Form 8-K is filed by Adherex Technologies Inc. (noting the metadata reference to Fennec Pharmaceuticals Inc. appears to be a discrepancy, as the filing text explicitly names Adherex Technologies Inc.) for the reporting period of December 5, 2008. The company is incorporated in Canada with principal executive offices in Durham, North Carolina. The filing addresses critical corporate governance and listing status events occurring in December 2008.
Key Financial Metrics and Liquidity
The filing does not provide specific revenue, profit, or cash flow figures for the current period. However, it discloses the following financial conditions triggering regulatory action:
- Stockholders' Equity: The company fails to meet the minimum requirement of at least US$6 million.
- Profitability: The company has sustained net losses in its five most recent fiscal years.
- Stock Price: The average selling price of the stock over the last six months was $0.14 per share.
- Liquidity/Capital Markets: Management cites "continuing turmoil in the capital markets" and a "current financial condition" as factors influencing their strategic decisions.
Material Changes and Delisting Notice
On December 5, 2008, the company received a notice from NYSE Alternext US LLC (formerly the American Stock Exchange) indicating failure to meet continued listing requirements. The specific deficiencies are:
- Failure to maintain minimum stockholders' equity of $6 million.
- Sustained net losses over the last five fiscal years.
- Low stock price requiring a reverse stock split under Section 1003(f)(v) of the Exchange's Company Guide.
Management does not currently plan to file a plan of compliance due to market conditions and the requirement for a reverse stock split. Consequently, the company expects delisting proceedings to begin promptly, with the last day of trading on the Exchange anticipated in early January 2009. The stock symbol will be noted with ".BC" to reflect non-compliance. Trading continues on the Toronto Stock Exchange under the symbol "AHX".
Management Commentary, Risks, and Incentive Programs
Executive Incentive Program: On December 10, 2008, the Board adopted a Success-Based Incentive Program for four executive officers. This program was created because share price erosion has rendered existing stock options essentially worthless. The program offers cash bonuses ranging from 1% to 5% of the transaction value upon the completion of a partnership, asset sale, or merger by July 31, 2009. Bonuses are offset dollar-for-dollar by any stock option value that returns to being "in the money."
Risks and Contingencies: The primary risk is the imminent delisting from NYSE Alternext US, which may impact liquidity and investor perception. The company faces the contingency of needing to secure a strategic transaction (merger or sale) to retain executive talent and potentially stabilize the business.
Investor Verification Checklist
- Verify the exact date of delisting from NYSE Alternext US and the transition to OTC trading.
- Confirm the current status of the company's stockholders' equity and whether it remains below the $6 million threshold.
- Monitor for any definitive agreements regarding partnerships, asset sales, or mergers before the July 31, 2009 deadline.
- Review the specific terms of the Success-Based Incentive Program attached as Exhibit 10.22 to understand potential cash outflows.
- Check the Toronto Stock Exchange (TSX) for continued trading activity and price stability under the "AHX" symbol.